Abstract:Mu Wang, 1, 2, &ast Jian Guo, 3, &ast Ailsa L Hart, 4 Jia V Li 1 1 Section of Nutrition, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, W12 0NN, UK; 2 Department of Neurology, Shanxi Provincial People's Hospital, the Affiliated People's Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, 030012, People's Republic of China; 3 Department of General Surgery, Shanxi Provincial People's Hospital, the Affiliated People's Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, 030012, People's Republic of China; 4 IBD Unit, St. Mark's Hospital, London, HA1 3UJ, UK &astThese authors contributed equally to this work Correspondence: Jia V Li, Section of Nutrition, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, W12 0NN, UK, Tel +44 20 7594 3230, Email Purpose: Indole-3-aldehyde (IAld) has been shown to improve intestinal epithelial barrier (IEB) function through the aryl hydrocarbon receptor (AhR) in murine colitis models. However, the impact of IAld on intestinal tissue inflammation remains unexplored. This study aimed to investigate the effects of IAld on the inflammatory responses of the gut both in vivo and in vitro and probe the mechanisms by which IAld attenuates colitis. Methods: The effects of IAld on phenotypic changes, pro-inflammatory cytokines, IEB functions and the faecal bacterial composition in mice with dextran sulfate sodium salt (DSS)-induced colitis were assessed. Macrophage cells and intestinal epithelial cells were stimulated with lipopolysaccharide (LPS), and the effects of IAld on the inflammatory responses and IBE functions were measured. Results: IAld reduced IL-6, IL-1β and TNF-α protein levels in both colonic tissues from the mice with colitis and LPS-stimulated macrophage cells. The IAld-mediated reduction of IL-6 but not IL-1β and TNF-α was through AhR activation. Furthermore, nuclear factor-κB pathway was found to be inhibited by IAld treatment via AhR activation both in vivo and in vitro. Gut permeability was significantly improved by IAld in both DSS-treated mice and LPS-stimulated Caco-2 cells. This observation is consistent with downregulation of phosphorylated myosin light chain through AhR activation. IAld did not appear to have an effect on the bacterial composition in mice with colitis despite the reduced colonic inflammatory responses. Conclusion: IAld improved DSS-induced colitis by inhibiting the inflammatory responses and restoring IEB function, partially via AhR activation. This work provided insight into the function of IAld in modulating gut inflammation. Keywords: indole-3-aldehyde aryl hydrocarbon receptor intestinal inflammation Graphical Ulcerative colitis (UC), a type of inflammatory bowel disease (IBD), is chronic immune-mediated inflammation occurring in the colon and rectum. 1 The main contributing factors to the pathogenesis of UC include an abnormal immune response of the mucosa and impaired intestinal epithelial barrier (IEB) functions. 1 These two pathogenic features result in devastating clinical consequences, such as rectal bleeding and diarrhoea. Although immunomodulators have frequently been used in treating patients with UC, therapeutic strategies remain a challenge owing to limited treatment options. 2 Recent advances in characterising gut microbial metabolism and metabolite functions have highlighted several microbial metabolites that improve intestinal homeostasis, including short-chain fatty acids (SCFAs), bile acid derivatives such as isoallolithocholic acid (isoalloLCA) 3 and tryptophan (Trp) metabolites. 4 Trp is an essential amino acid that is exclusively supplied by diet. Trp is metabolised in the mammalian gut in three main pathways, including the kynurenine pathway, serotonin pathway and through the bacterial pathway to produce indole and indole derivatives, 5 eg, indole-3-pyruvate (IPyA), indole-3-aldehyde (IAld), and indole propionic acid (IPA). 6 A lower level of serum Trp was observed in patients with UC compared to healthy subjects. 7 In addition, faecal levels of Trp, kynurenine and indole-3-acetic acid (IAA) in patients with UC were significantly different from those in healthy individuals. 8 Trp supplementation to mice with colitis alleviated the intestinal inflammation. 9,10 The anti-inflammatory effects of Trp and its metabolites such as IPA on experimental colitis have been proposed to occur through -Abstract Truncated-

Impaired Indole Acetic Acid and Reduced Indole-Producing Bacteria Contribute to Swainsonine-Induced Liver Inflammation.

Swainsonine Induces Liver Inflammation in Mice Via Disturbance of Gut Microbiota and Bile Acid Metabolism

Increased intestinal permeability and lipopolysaccharide contribute to swainsonine-induced systemic inflammation

Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway

Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure <i>via</i> the Tlr2/NF-B pathway

Protective Role of Indole-3-Acetic Acid Against Salmonella Typhimurium: Inflammation Moderation and Intestinal Microbiota Restoration

The gut microbiota metabolite indole alleviates liver inflammation in mice

Microbiota-derived Indoles Alleviate Intestinal Inflammation and Modulate Microbiome by Microbial Cross-Feeding

DOP35 High-fat diet reduces gut microbiota-derived metabolite indole-acetic acid and aggravates colitis

Indole-3-Aldehyde Reduces Inflammatory Responses and Restores Intestinal Epithelial Barrier Function Partially via Aryl Hydrocarbon Receptor (AhR) in Experimental Colitis Models

Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation

Therapeutic Potential of Foodborne Indole Derived from Chinese Stinky Tofu in Reducing Intestinal Inflammation and Enhancing Barrier Function to Mitigate Alcoholic Liver Injury

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

Potential degradation of swainsonine by intracellular enzymes of Arthrobacter sp. HW08.

Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice

Protective Effects of Microbiome-Derived Inosine on Lipopolysaccharide-Induced Acute Liver Damage and Inflammation in Mice via Mediating the TLR4/NF-κB Pathway

Bacterial indole-3-lactic acid affects epithelium-macrophage crosstalk to regulate intestinal homeostasis

Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice

Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice

Indole-3-acetamide from gut microbiota activated hepatic AhR and mediated the remission effect of Lactiplantibacillus plantarum P101 on alcoholic liver injury in mice

Metagenomic analysis reveals indole signaling effect on microbial community in sequencing batch reactors: Quorum sensing inhibition and antibiotic resistance enrichment